Neuro-Oncology Reviews
Volume
26 Number 29
20 December 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 29, 20 December
Palavani LB, Semione G, de Oliveira Almeida G, Lepine HL, Borges
P, Nogueira BV, Lúcia G, Ferreira MY, Pereira A, Batista da
Hora DA, de Jesus Leone Pereira M, Torregrossa F, Nigris
Vasconcellos F, Bertani R, Bastianon R, Benjamin C, Formentin
C.
Evaluating the safety and efficacy
of proton radiotherapy for intracranial pediatric ependymomas: A
single-arm meta-analysis.
J
Clin Neurosci. 2024 Dec 11;132:110977. doi:
10.1016/j.jocn.2024.110977? PMID:
39662113. Review; Meta-anallysis˰
ˍ
Zhang Y, Zhang Q, Liu R, Zhang D, Hu G, Chen X.
Circadian
disruption in cancer
and regulation of cancer stem cells by circadian clock genes: An
updated review.
Cancer
Lett. 2024 Dec 11:217391. doi:
10.1016/j.canlet.2024.217391. PMID:
39672457. Review. ˍ
Vachha BA, Kumar VA, Pillai JJ, Shimony J, Tanabe J, Sair HI.
Resting-State Functional MRI: Current
State, Controversies, Limitations, and Future Directions-AJR
Expert Panel Narrative Review.
AJR
Am J Roentgenol. 2024 Dec 11. doi:
10.2214/AJR.24.32163. PMID:
39660823. Review˰ ˍ
Mondia MWL, Hooks RE, Maragkos GA, Smith VL, McCord MR, Donahue
JH, Williams ES, Lopes MB, Schiff D, Asthagiri AR.
Primary
diffuse leptomeningeal glioblastoma: a case report and literature
review.
J
Neurooncol. 2024 Dec 12. doi:
10.1007/s11060-024-04908-8. PMID:
39666263. Case report; Review. ˍ
Taori S, Habib A, Adida S, Gecici NN, Sharma N, Calcaterra M, Tang
A, Pandya S, Mehra A, Deng H, Elidrissy H, Idrissi YA, Amjadzadeh
M, Zinn PO.
Circulating biomarkers in
high-grade gliomas: current insights and future perspectives.
J
Neurooncol. 2024 Dec 13. doi:
10.1007/s11060-024-04903-z. PMID:
39671020. Review˰ ˍ
D'Arcy CE, Hawkins CE.
A pathologist's
guide for the diagnostic workup of paediatric central nervous
system tumours.
Pathology.
2024 Nov 12:S0031-3025(24)00290-3. doi:
10.1016/j.pathol.2024.10.002. PMID:
39658395. Review; Practical guide˰
ˍ
Grutza M, Lenga P, Issa M, Seitz A, Sahm F, Milde T, Unterberg AW,
Krieg SM, El Damaty A.
Pediatric skull
base tumors: Clinical features and surgical outcomes; a single
center retrospective study with a review of literature.
Brain
Spine. 2024 Nov 13;4:104136. doi:
10.1016/j.bas.2024.104136. PMID:
39687083. Observational study; Review. ˍ
AlSindi T, Alghamdi KT, Alghamdi AM, Samkari A, Kutub H.
Intraventricular Glioblastoma in a
Neonate: A Case Report and Literature Review.
Cureus.
2024 Nov 16;16(11):e73797. doi:
10.7759/cureus.73797. PMID:
39691110. Case report; Review. ˍ
Nadeem SF, Fatima H, Javed Z, Shamim MS.
Radiation-Induced
Leukoencephalopathy in Glioma Patients.
J
Pak Med Assoc. 2024 Nov 17;74(12):2199-2201. doi:
10.47391/JPMA.24-101. PMID:
39658999. Review. ˍ
Broggi G, Salzano S, Failla M, Barbagallo GMV, Certo F, Zanelli M,
Palicelli A, Zizzo M, Koufopoulos N, Magro G, Caltabiano
R.
Clinico-Pathological Features of
Diffuse Midline Glioma, H3 K27-Altered in Adults: A Comprehensive
Review of the Literature with an Additional Single-Institution
Case Series.
Diagnostics
(Basel). 2024 Nov 21;14(23):2617. doi:
10.3390/diagnostics14232617. PMID:
39682526. Case report; Review. ˍ
Babič D, Jovčevska I, Zottel A.
B7-H3
in glioblastoma and beyond: significance and therapeutic
strategies.
Front
Immunol. 2024 Nov 25;15:1495283. doi:
10.3389/fimmu.2024.1495283. PMID:
39664380. Review. ˍ
Liu X, Chen H, Tan G, Zhong L, Jiang H, Smith SM, Wang HZ.
A
comprehensive neuroimaging review of the primary and metastatic
brain tumors treated with immunotherapy: current status, and the
application of advanced imaging approaches and artificial
intelligence.
Front
Immunol. 2024 Nov 28;15:1496627. doi:
10.3389/fimmu.2024.1496627. PMID:
39669560. Review. ˍ
Wahid MA, Khan MT, Hussain JM, Malik H, Umar SA, Mughal S,
Hasanain M, Anjum MU, Mahmmoud Fadelallah Eljack M.
Emerging
paradigm: Molecularly targeted therapy with Dabrafenib and
Trametinib in recurring pediatric gliomas with BRAF mutations: A
narrative review.
Medicine
(Baltimore). 2024 Dec 6;103(49):e40735. doi:
10.1097/MD.0000000000040735. PMID:
39654184. Review. ˍ
Gerritsen JKW, Karschnia P, Young JS, van den Bent MJ, Chang SM,
Smith TR, Nahed BV, Rincon-Torroella J, Bettegowda C, Sanai N,
Krieg SM, Maruyama T, Schucht P, Broekman MLD, Tonn JC, Wen PY, De
Vleeschouwer S, Vincent AJPE, Hervey-Jumper S, Berger MS, Mekary
RA, Molinaro AM.
Practical and
statistical aspects of subgroup analyses in surgical
neuro-oncology: A comprehensive review from the PIONEER
Consortium.
Neuro
Oncol. 2024 Dec 7:noae261. doi:
10.1093/neuonc/noae261. PMID:
39657588. Review; Practical guide. ˍ
Mesas C, Moreno J, Doello K, Peña M, López-Romero
JM, Prados J, Melguizo C.
Cannabidiol
effects in stem cells: A systematic review.
Biofactors.
2024 Dec 9. doi:
10.1002/biof.2148. PMID:
39653426. Review. ˍ
Vychopen M, Güresir A, Basaran AE, Güresir E, Wach J.
Impact of levetiracetam use in
glioblastoma: an individual patient-level meta-analysis assessing
overall survival.
Neurosurg
Rev. 2024 Dec 9;47(1):897. doi:
10.1007/s10143-024-03137-x. PMID:
39653818. Meta-analysis. ˍ
Chassé M, Vasdev N.
PET in
neurotherapeutic discovery and development.
Neurotherapeutics.
2024 Dec 10:e00498. doi:
10.1016/j.neurot.2024.e00498. PMID:
39665954. Perspective. ˍ
Harbi E, Aschner M.
Role of BRCA1 in
glioblastoma etiology.
Cell
Oncol (Dordr). 2024 Dec 10. doi:
10.1007/s13402-024-01024-7. PMID:
39656422. Review˰ ˍ
Shiroishi MS, Erickson BJ, Hu LS, Barboriak DP, Becerra L, Bell
LC, Boss MA, Boxerman JL, Cen S, Cimino L, Fan Z, Keenan KE,
Kirsch JE, Ameli N, Nazemi S, Quarles CC, Rosen MA, Rodriguez L,
Schmainda KM, Zahlmann G, Zhou Y, Obuchowski N, Wu O; RSNA QIBA
Dynamic Susceptibility Contrast MRI Biomarker Committee.
The
QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative
Imaging Biomarkers for Assessing Gliomas.
Radiology.
2024 Dec 10;313(3):e232555. doi:
10.1148/radiol.232555. PMID:
39656118. Review˰ ˍ